RenovoRx (RNXT) Capital Expenditures (2025)

RenovoRx (RNXT) has disclosed Capital Expenditures for 1 consecutive years, with $2000.0 as the latest value for Q1 2025.

  • Quarterly Capital Expenditures changed N/A to $2000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $2000.0 for FY2025, 83.33% down from the prior year.
  • Capital Expenditures hit $2000.0 in Q1 2025 for RenovoRx.
  • In the past five years, Capital Expenditures ranged from a high of $2000.0 in Q1 2025 to a low of $2000.0 in Q1 2025.